Lv7
5000 积分 2022-09-16 加入
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study
29天前
已完结
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial
3个月前
已完结
LB0008 SAP-001, A FIRST –IN-CLASS COMPOUND TARGETING A RENAL URATE TRANSPORTER, SHOWS POTENT SERUM URATE-LOWERING EFFECTS AND FAVORABLE SAFETY PROFILE IN A US PHASE 2b STUDY IN PATIENTS WITH REFRACTORY GOUT WITH OR WITHOUT PALPABLE TOPHI
3个月前
已完结
Amitriptyline versus placebo in postherpetic neuralgia
5个月前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
6个月前
已完结
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
6个月前
已完结
Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system
8个月前
已完结
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
8个月前
已完结
Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies
9个月前
已完结
皖公网安备34019202002308
